Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
Conditions
Pain
What is the purpose of this trial?
The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy.
Participation Guidelines
- Age:
- 6 Years - 16 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Purdue Pharma LP
- Dates:
- November 2010
- Last Updated:
- March 20, 2013
- Study HIC#:
- 1107008863
Clinicaltrials.gov ID: NCT01192295
